These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

879 related items for PubMed ID: 28122086

  • 21. Effect of Rapamycin Microspheres in Sjögren Syndrome Dry Eye: Preparation and Outcomes.
    Wang S, Wang M, Liu Y, Hu D, Gu L, Fei X, Zhang J.
    Ocul Immunol Inflamm; 2019; 27(8):1357-1364. PubMed ID: 30273514
    [Abstract] [Full Text] [Related]

  • 22. Intralacrimal Sustained Delivery of Rapamycin Shows Therapeutic Effects without Systemic Toxicity in a Mouse Model of Autoimmune Dacryoadenitis Characteristic of Sjögren's Syndrome.
    Ju Y, Edman MC, Guo H, Janga SR, Peddi S, Louie SG, Junge JA, MacKay JA, Hamm-Alvarez SF.
    Biomacromolecules; 2021 Mar 08; 22(3):1102-1114. PubMed ID: 33356170
    [Abstract] [Full Text] [Related]

  • 23. The Effect of Mesenchymal Stem Cells on Dry Eye in Sjogren Syndrome Mouse Model.
    Shin S, Yoon SG, Kim M, Cheon EJ, Jeon Y, Lee HJ, Chung SH.
    Int J Mol Sci; 2023 Jan 05; 24(2):. PubMed ID: 36674547
    [Abstract] [Full Text] [Related]

  • 24. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
    Ushio A, Arakaki R, Eguchi H, Hotta F, Yamada A, Kudo Y, Ishimaru N.
    Int J Mol Sci; 2017 Jun 06; 18(6):. PubMed ID: 28587293
    [Abstract] [Full Text] [Related]

  • 25. Imbalanced Rab3D versus Rab27 increases cathepsin S secretion from lacrimal acini in a mouse model of Sjögren's Syndrome.
    Meng Z, Edman MC, Hsueh PY, Chen CY, Klinngam W, Tolmachova T, Okamoto CT, Hamm-Alvarez SF.
    Am J Physiol Cell Physiol; 2016 Jun 01; 310(11):C942-54. PubMed ID: 27076615
    [Abstract] [Full Text] [Related]

  • 26. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
    Czerwinski S, Mostafa S, Rowan VS, Azzarolo AM.
    Exp Eye Res; 2014 Nov 01; 128():15-22. PubMed ID: 25218176
    [Abstract] [Full Text] [Related]

  • 27. The Effect of Chloroquine on the Development of Dry Eye in Sjögren Syndrome Animal Model.
    Lee HJ, Shin S, Yoon SG, Cheon EJ, Chung SH.
    Invest Ophthalmol Vis Sci; 2019 Sep 03; 60(12):3708-3716. PubMed ID: 31479110
    [Abstract] [Full Text] [Related]

  • 28. Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjögren's syndrome.
    Paranyuk Y, Claros N, Birzgalis A, Moore LC, Brink PR, Walcott B.
    Curr Eye Res; 2001 Sep 03; 23(3):199-205. PubMed ID: 11803482
    [Abstract] [Full Text] [Related]

  • 29. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
    Bian F, Barbosa FL, Corrales RM, Pelegrino FS, Volpe EA, Pflugfelder SC, de Paiva CS.
    Arthritis Res Ther; 2015 Mar 10; 17(1):53. PubMed ID: 25889094
    [Abstract] [Full Text] [Related]

  • 30. Tear miRNAs Identified in a Murine Model of Sjögren's Syndrome as Potential Diagnostic Biomarkers and Indicators of Disease Mechanism.
    Kakan SS, Edman MC, Yao A, Okamoto CT, Nguyen A, Hjelm BE, Hamm-Alvarez SF.
    Front Immunol; 2022 Mar 10; 13():833254. PubMed ID: 35309364
    [Abstract] [Full Text] [Related]

  • 31. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
    Nagelhout TJ, Gamache DA, Roberts L, Brady MT, Yanni JM.
    J Ocul Pharmacol Ther; 2005 Apr 10; 21(2):139-48. PubMed ID: 15857280
    [Abstract] [Full Text] [Related]

  • 32. Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome.
    Aluri HS, Kublin CL, Thotakura S, Armaos H, Samizadeh M, Hawley D, Thomas WM, Leavis P, Makarenkova HP, Zoukhri D.
    Invest Ophthalmol Vis Sci; 2015 Aug 10; 56(9):5218-28. PubMed ID: 26244298
    [Abstract] [Full Text] [Related]

  • 33. Tear cathepsin S as a candidate biomarker for Sjögren's syndrome.
    Hamm-Alvarez SF, Janga SR, Edman MC, Madrigal S, Shah M, Frousiakis SE, Renduchintala K, Zhu J, Bricel S, Silka K, Bach D, Heur M, Christianakis S, Arkfeld DG, Irvine J, Mack WJ, Stohl W.
    Arthritis Rheumatol; 2014 Jul 10; 66(7):1872-81. PubMed ID: 24644101
    [Abstract] [Full Text] [Related]

  • 34. Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse.
    Li X, Wu K, Edman M, Schenke-Layland K, MacVeigh-Aloni M, Janga SR, Schulz B, Hamm-Alvarez SF.
    Invest Ophthalmol Vis Sci; 2010 Oct 10; 51(10):5019-29. PubMed ID: 20463324
    [Abstract] [Full Text] [Related]

  • 35. [Current treatments of xerophthalmia in Sjögren's syndrome].
    Baudouin C, Pisella PJ, Brignole F.
    Rev Med Interne; 2004 May 10; 25(5):376-82. PubMed ID: 15110955
    [Abstract] [Full Text] [Related]

  • 36. Lacrimal histopathology and ocular surface disease in a rabbit model of autoimmune dacryoadenitis.
    Zhu Z, Stevenson D, Schechter JE, Mircheff AK, Atkinson R, Trousdale MD.
    Cornea; 2003 Jan 10; 22(1):25-32. PubMed ID: 12502944
    [Abstract] [Full Text] [Related]

  • 37. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
    Moscovici BK, Holzchuh R, Sakassegawa-Naves FE, Hoshino-Ruiz DR, Albers MB, Santo RM, Hida RY.
    Cont Lens Anterior Eye; 2015 Oct 10; 38(5):373-8. PubMed ID: 25956572
    [Abstract] [Full Text] [Related]

  • 38. NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis.
    Ju Y, Janga SR, Klinngam W, MacKay JA, Hawley D, Zoukhri D, Edman MC, Hamm-Alvarez SF.
    Exp Eye Res; 2018 Nov 10; 176():243-251. PubMed ID: 30201519
    [Abstract] [Full Text] [Related]

  • 39. c-Jun NH2-terminal kinase mediates interleukin-1beta-induced inhibition of lacrimal gland secretion.
    Zoukhri D, Macari E, Choi SH, Kublin CL.
    J Neurochem; 2006 Jan 10; 96(1):126-35. PubMed ID: 16300639
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.